1. Ackerman DL, Doster RS, Weitkamp JH, Aronoff DM, Gaddy JA, Townsend SD (2017) Human milk oligosaccharides exhibit antimicrobial and antibiofilm properties against Group B Streptococcus. ACS Infect Dis 3:595–605
2. Armistead B, Oler E, Adams Waldorf K, Rajagopal L (2019) The double life of Group B Streptococcus: asymptomatic colonizer and potent pathogen. J Mol Biol 431(16):2914–2931
3. Baker CJ (2013) The spectrum of perinatal Group B streptococcal disease. Vaccine 31S:D3–D6
4. Biasi-Garbin RP, Otaguiri ES, Morey AT, da Silva MF, Morguette AEB, Lancheros CAC, Kian D, Perugini MRE, Nakazato G, Duran N, Nakamura CV, Yamauchi LM, Yamada-Ogatta SF (2015) Effect of eugenol against Streptococcus agalactiae and synergistic interaction with biologically produced silver nanoparticles. Evid Based Complement Alternat Med 2015:861497
5. Boonyayatra S, Pata P, Nakharuthai P, Chaisri W (2016) Antimicrobial resistance of biofilm-forming Streptococcus agalactiae isolated from bovine mastitis. J Veter Sci Technol 7:5